Inhaled Nitric Oxide Delivery Systems Market Trends

Growth Drivers

• Growing Demand for Non-Invasive Treatment - The market size of the inhalation nitric oxide delivery systems is likely to be increased by increasing demand for noninvasive treatments, e.g. inhaled nitric oxide (INO). Noninvasive treatments are generally well tolerated and have fewer side effects than more invasive treatments, which may make them more attractive to patients and healthcare providers. Therefore, the demand for noninvasive treatments such as INO could increase and therefore nitric oxide delivery devices would be needed more.
• Prevalence of Respiratory Disease - The growth of the inhaled nitric oxide delivery systems market over the forecast period is expected to be driven by an increase in the incidence and prevalence of respiratory disorders. The market for NO delivery systemss is further expected to be driven by an increasing incidence of respiratory infections such as SARS, COVID 19 and others. In the United States, approximately 1.8 million cases of coronavirus have been reported since May 2020. In addition, the United States Food and Drug Administration has approved an emergency use of a GENOSYL NO delivery systems manufactured by VERO Biotech in critically ill COVID19 patients with respiratory failure. The demand for inhaled nitric oxide delivery systemss in the country is expected to increase as a result of this trend.
• High Prevalence of Hypoxemic Respiratory Failure in Pediatrics - In infants and children, inhaled nitric oxide is also used for the treatment of hypoxemic respiratory failure. This condition occurs when there's not enough oxygen in the blood. Various underlying conditions such as asthma, pneumonia and respiratory tract infections may also be to blame. INO works by relaxing the muscles on the walls of the blood vessels in the lungs, allowing the blood to flow more freely and increasing the amount of oxygen delivered to the tissues of the body.

Challenges

• Technical Complexities Associated – Current systemss are bulky and complex requiring trained professionals to operate and monitor. This can be a barrier to wider use, especially outside of intensive care units.
• Safety Concerns Associated with the systems are expected to hamper the market growth in the forecast period
• Evolving regulatory landscape are expected to hinder the nitric oxide delivery systems market growth in the projected period.